MARCHF1 and ovarian cancer: A study found that MARCH1 is overexpressed in ovarian cancer tissues and that MARCH1 silencing inhibited the proliferation, invasion, and migration of SKOV3 cells via the mediation of the nuclear factor‐κB (NF‐κB) and the Wnt/β‐catenin pathways (Meng et al., 2016).